Stockreport

GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates

GH Research PLC - Ordinary Shares  (GHRS) 
PDF Phase 2b clinical trial of GH001 in patients with treatment-resistant depression completed enrolment of the double-blind phase in Q3 2024Phase 1 clinical trial to evalua [Read more]